Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease

Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational stroke research 2019-10, Vol.10 (5), p.495-508
Hauptverfasser: van Kralingen, Josie C., McFall, Aisling, Ord, Emily N. J., Coyle, Thomas F., Bissett, Maria, McClure, John D., McCabe, Christopher, Macrae, I. Mhairi, Dawson, Jesse, Work, Lorraine M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 508
container_issue 5
container_start_page 495
container_title Translational stroke research
container_volume 10
creator van Kralingen, Josie C.
McFall, Aisling
Ord, Emily N. J.
Coyle, Thomas F.
Bissett, Maria
McClure, John D.
McCabe, Christopher
Macrae, I. Mhairi
Dawson, Jesse
Work, Lorraine M.
description Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbiased miRNA microarray was performed in stroke vs. stroke mimic patients ( n  = 39). Results were validated ( n  = 173 patients) by real-time quantitative polymerase chain reaction. miRNA expression was quantified in total serum/EV ( n  = 5–7) of naïve adult spontaneously hypertensive stroke-prone rats (SHRSP), their normotensive reference strain (Wistar Kyoto, WKY) and in circulating EV ( n  = 3), peri-infarct brain ( n  = 6), or EV derived from this region ( n  = 3) in SHRSP following transient middle cerebral artery occlusion (tMCAO). Circulating EV concentration did not differ between stroke and stroke mimic patients. The microarray identified many altered EV-packaged miRNAs: levels of miRNA-17-5p, -20b-5p and -93-5p (miRNA-17 family members) and miRNA-27b-3p were significantly ( p  ≤ 0.05) increased in stroke vs. stroke mimic patients. Patients with small vessel disease (SVD) consistently had the highest miRNA levels. Circulating EV concentration was unaltered between naïve SHRSP and WKY but levels of miRNA-17-5p and -93-5p were significantly increased in SHRSP. tMCAO in SHRSP did not further alter circulating EV miRNA-17 family member expression and nor did it change total miRNA-17 family levels in peri-infarct brain tissue or in EV isolated from this region at 24 h post-tMCAO. Changes in EV packaged miRNA expression was validated in patients with stroke, particularly those with SVD and corroborated pre-clinically. Together, altered circulating EV levels of miRNA-17 family members may reflect the chronic sequelae underlying cerebrovascular SVD rather than the acute ischemic stroke itself.
doi_str_mv 10.1007/s12975-018-0682-3
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920241253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-e9a7ac081b6f0b08a56a8ed3e44956c5df1a7283155a7fc43b48b38e440dbe113</originalsourceid><addsrcrecordid>eNp1UU1rFTEUDaLYUvsD3EjAjZuxuUkmk9kIj7bWQqtgW3EjIZO506ZmZp7JTNF_3wzvtX6A2SRwPm7OPYS8BPYWGKsOEvC6KgsGumBK80I8IbuglS4Ug69Pt28ptdgh-yndsnwESCXFc7IjmIKqrvku-bYKE0Zs6fHPKVqHIczBRvoFk3cB6bl3cfz8cZXhdcSU_DhQP9DT5G6w945eTHH8jtQOLb3obQiLMGGgRz6hTfiCPOtsSLi_vffI1fvjy8MPxdmnk9PD1VnhZMWmAmtbWcc0NKpjDdO2VFZjK1DKulSubDuwFdcCytJWnZOikboROsOsbRBA7JF3G9_13PTYOhxymGDW0fc2_jKj9eZvZPA35nq8M6oSQoPIBm-2BnH8MWOaTO_Tsg074Dgnw0GVrK614pn6-h_q7TjHIcczvOaMS-DlYggbVt5fShG7x88AM0t_ZtOfyf2ZpT-zaF79meJR8dBWJvANIWVouMb4e_T_Xe8BRx6mGg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920241253</pqid></control><display><type>article</type><title>Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease</title><source>MEDLINE</source><source>ProQuest Central (Alumni)</source><source>ProQuest Central UK/Ireland</source><source>SpringerNature Journals</source><source>ProQuest Central</source><creator>van Kralingen, Josie C. ; McFall, Aisling ; Ord, Emily N. J. ; Coyle, Thomas F. ; Bissett, Maria ; McClure, John D. ; McCabe, Christopher ; Macrae, I. Mhairi ; Dawson, Jesse ; Work, Lorraine M.</creator><creatorcontrib>van Kralingen, Josie C. ; McFall, Aisling ; Ord, Emily N. J. ; Coyle, Thomas F. ; Bissett, Maria ; McClure, John D. ; McCabe, Christopher ; Macrae, I. Mhairi ; Dawson, Jesse ; Work, Lorraine M.</creatorcontrib><description>Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbiased miRNA microarray was performed in stroke vs. stroke mimic patients ( n  = 39). Results were validated ( n  = 173 patients) by real-time quantitative polymerase chain reaction. miRNA expression was quantified in total serum/EV ( n  = 5–7) of naïve adult spontaneously hypertensive stroke-prone rats (SHRSP), their normotensive reference strain (Wistar Kyoto, WKY) and in circulating EV ( n  = 3), peri-infarct brain ( n  = 6), or EV derived from this region ( n  = 3) in SHRSP following transient middle cerebral artery occlusion (tMCAO). Circulating EV concentration did not differ between stroke and stroke mimic patients. The microarray identified many altered EV-packaged miRNAs: levels of miRNA-17-5p, -20b-5p and -93-5p (miRNA-17 family members) and miRNA-27b-3p were significantly ( p  ≤ 0.05) increased in stroke vs. stroke mimic patients. Patients with small vessel disease (SVD) consistently had the highest miRNA levels. Circulating EV concentration was unaltered between naïve SHRSP and WKY but levels of miRNA-17-5p and -93-5p were significantly increased in SHRSP. tMCAO in SHRSP did not further alter circulating EV miRNA-17 family member expression and nor did it change total miRNA-17 family levels in peri-infarct brain tissue or in EV isolated from this region at 24 h post-tMCAO. Changes in EV packaged miRNA expression was validated in patients with stroke, particularly those with SVD and corroborated pre-clinically. Together, altered circulating EV levels of miRNA-17 family members may reflect the chronic sequelae underlying cerebrovascular SVD rather than the acute ischemic stroke itself.</description><identifier>ISSN: 1868-4483</identifier><identifier>EISSN: 1868-601X</identifier><identifier>DOI: 10.1007/s12975-018-0682-3</identifier><identifier>PMID: 30617992</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; Brain Ischemia - blood ; Brain research ; Cardiology ; Cerebral Small Vessel Diseases - blood ; Disease Models, Animal ; Extracellular Vesicles - metabolism ; Genes ; Ischemia ; Male ; MicroRNAs ; MicroRNAs - blood ; Neurology ; Neurosciences ; Neurosurgery ; Original ; Original Article ; Patients ; Rats, Inbred SHR ; Rats, Inbred WKY ; Software ; Statistical analysis ; Stroke ; Stroke - blood ; Stroke - complications ; Thermal cycling ; Validation studies ; Vascular Surgery ; Veins &amp; arteries</subject><ispartof>Translational stroke research, 2019-10, Vol.10 (5), p.495-508</ispartof><rights>The Author(s) 2019</rights><rights>The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-e9a7ac081b6f0b08a56a8ed3e44956c5df1a7283155a7fc43b48b38e440dbe113</citedby><cites>FETCH-LOGICAL-c470t-e9a7ac081b6f0b08a56a8ed3e44956c5df1a7283155a7fc43b48b38e440dbe113</cites><orcidid>0000-0002-6462-4109</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12975-018-0682-3$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2920241253?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,21388,21389,27924,27925,33530,33531,33744,33745,41488,42557,43659,43805,51319,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30617992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Kralingen, Josie C.</creatorcontrib><creatorcontrib>McFall, Aisling</creatorcontrib><creatorcontrib>Ord, Emily N. J.</creatorcontrib><creatorcontrib>Coyle, Thomas F.</creatorcontrib><creatorcontrib>Bissett, Maria</creatorcontrib><creatorcontrib>McClure, John D.</creatorcontrib><creatorcontrib>McCabe, Christopher</creatorcontrib><creatorcontrib>Macrae, I. Mhairi</creatorcontrib><creatorcontrib>Dawson, Jesse</creatorcontrib><creatorcontrib>Work, Lorraine M.</creatorcontrib><title>Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease</title><title>Translational stroke research</title><addtitle>Transl. Stroke Res</addtitle><addtitle>Transl Stroke Res</addtitle><description>Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbiased miRNA microarray was performed in stroke vs. stroke mimic patients ( n  = 39). Results were validated ( n  = 173 patients) by real-time quantitative polymerase chain reaction. miRNA expression was quantified in total serum/EV ( n  = 5–7) of naïve adult spontaneously hypertensive stroke-prone rats (SHRSP), their normotensive reference strain (Wistar Kyoto, WKY) and in circulating EV ( n  = 3), peri-infarct brain ( n  = 6), or EV derived from this region ( n  = 3) in SHRSP following transient middle cerebral artery occlusion (tMCAO). Circulating EV concentration did not differ between stroke and stroke mimic patients. The microarray identified many altered EV-packaged miRNAs: levels of miRNA-17-5p, -20b-5p and -93-5p (miRNA-17 family members) and miRNA-27b-3p were significantly ( p  ≤ 0.05) increased in stroke vs. stroke mimic patients. Patients with small vessel disease (SVD) consistently had the highest miRNA levels. Circulating EV concentration was unaltered between naïve SHRSP and WKY but levels of miRNA-17-5p and -93-5p were significantly increased in SHRSP. tMCAO in SHRSP did not further alter circulating EV miRNA-17 family member expression and nor did it change total miRNA-17 family levels in peri-infarct brain tissue or in EV isolated from this region at 24 h post-tMCAO. Changes in EV packaged miRNA expression was validated in patients with stroke, particularly those with SVD and corroborated pre-clinically. Together, altered circulating EV levels of miRNA-17 family members may reflect the chronic sequelae underlying cerebrovascular SVD rather than the acute ischemic stroke itself.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain Ischemia - blood</subject><subject>Brain research</subject><subject>Cardiology</subject><subject>Cerebral Small Vessel Diseases - blood</subject><subject>Disease Models, Animal</subject><subject>Extracellular Vesicles - metabolism</subject><subject>Genes</subject><subject>Ischemia</subject><subject>Male</subject><subject>MicroRNAs</subject><subject>MicroRNAs - blood</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Inbred WKY</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Stroke</subject><subject>Stroke - blood</subject><subject>Stroke - complications</subject><subject>Thermal cycling</subject><subject>Validation studies</subject><subject>Vascular Surgery</subject><subject>Veins &amp; arteries</subject><issn>1868-4483</issn><issn>1868-601X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1UU1rFTEUDaLYUvsD3EjAjZuxuUkmk9kIj7bWQqtgW3EjIZO506ZmZp7JTNF_3wzvtX6A2SRwPm7OPYS8BPYWGKsOEvC6KgsGumBK80I8IbuglS4Ug69Pt28ptdgh-yndsnwESCXFc7IjmIKqrvku-bYKE0Zs6fHPKVqHIczBRvoFk3cB6bl3cfz8cZXhdcSU_DhQP9DT5G6w945eTHH8jtQOLb3obQiLMGGgRz6hTfiCPOtsSLi_vffI1fvjy8MPxdmnk9PD1VnhZMWmAmtbWcc0NKpjDdO2VFZjK1DKulSubDuwFdcCytJWnZOikboROsOsbRBA7JF3G9_13PTYOhxymGDW0fc2_jKj9eZvZPA35nq8M6oSQoPIBm-2BnH8MWOaTO_Tsg074Dgnw0GVrK614pn6-h_q7TjHIcczvOaMS-DlYggbVt5fShG7x88AM0t_ZtOfyf2ZpT-zaF79meJR8dBWJvANIWVouMb4e_T_Xe8BRx6mGg</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>van Kralingen, Josie C.</creator><creator>McFall, Aisling</creator><creator>Ord, Emily N. J.</creator><creator>Coyle, Thomas F.</creator><creator>Bissett, Maria</creator><creator>McClure, John D.</creator><creator>McCabe, Christopher</creator><creator>Macrae, I. Mhairi</creator><creator>Dawson, Jesse</creator><creator>Work, Lorraine M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6462-4109</orcidid></search><sort><creationdate>20191001</creationdate><title>Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease</title><author>van Kralingen, Josie C. ; McFall, Aisling ; Ord, Emily N. J. ; Coyle, Thomas F. ; Bissett, Maria ; McClure, John D. ; McCabe, Christopher ; Macrae, I. Mhairi ; Dawson, Jesse ; Work, Lorraine M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-e9a7ac081b6f0b08a56a8ed3e44956c5df1a7283155a7fc43b48b38e440dbe113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain Ischemia - blood</topic><topic>Brain research</topic><topic>Cardiology</topic><topic>Cerebral Small Vessel Diseases - blood</topic><topic>Disease Models, Animal</topic><topic>Extracellular Vesicles - metabolism</topic><topic>Genes</topic><topic>Ischemia</topic><topic>Male</topic><topic>MicroRNAs</topic><topic>MicroRNAs - blood</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Inbred WKY</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Stroke</topic><topic>Stroke - blood</topic><topic>Stroke - complications</topic><topic>Thermal cycling</topic><topic>Validation studies</topic><topic>Vascular Surgery</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Kralingen, Josie C.</creatorcontrib><creatorcontrib>McFall, Aisling</creatorcontrib><creatorcontrib>Ord, Emily N. J.</creatorcontrib><creatorcontrib>Coyle, Thomas F.</creatorcontrib><creatorcontrib>Bissett, Maria</creatorcontrib><creatorcontrib>McClure, John D.</creatorcontrib><creatorcontrib>McCabe, Christopher</creatorcontrib><creatorcontrib>Macrae, I. Mhairi</creatorcontrib><creatorcontrib>Dawson, Jesse</creatorcontrib><creatorcontrib>Work, Lorraine M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational stroke research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Kralingen, Josie C.</au><au>McFall, Aisling</au><au>Ord, Emily N. J.</au><au>Coyle, Thomas F.</au><au>Bissett, Maria</au><au>McClure, John D.</au><au>McCabe, Christopher</au><au>Macrae, I. Mhairi</au><au>Dawson, Jesse</au><au>Work, Lorraine M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease</atitle><jtitle>Translational stroke research</jtitle><stitle>Transl. Stroke Res</stitle><addtitle>Transl Stroke Res</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>10</volume><issue>5</issue><spage>495</spage><epage>508</epage><pages>495-508</pages><issn>1868-4483</issn><eissn>1868-601X</eissn><abstract>Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbiased miRNA microarray was performed in stroke vs. stroke mimic patients ( n  = 39). Results were validated ( n  = 173 patients) by real-time quantitative polymerase chain reaction. miRNA expression was quantified in total serum/EV ( n  = 5–7) of naïve adult spontaneously hypertensive stroke-prone rats (SHRSP), their normotensive reference strain (Wistar Kyoto, WKY) and in circulating EV ( n  = 3), peri-infarct brain ( n  = 6), or EV derived from this region ( n  = 3) in SHRSP following transient middle cerebral artery occlusion (tMCAO). Circulating EV concentration did not differ between stroke and stroke mimic patients. The microarray identified many altered EV-packaged miRNAs: levels of miRNA-17-5p, -20b-5p and -93-5p (miRNA-17 family members) and miRNA-27b-3p were significantly ( p  ≤ 0.05) increased in stroke vs. stroke mimic patients. Patients with small vessel disease (SVD) consistently had the highest miRNA levels. Circulating EV concentration was unaltered between naïve SHRSP and WKY but levels of miRNA-17-5p and -93-5p were significantly increased in SHRSP. tMCAO in SHRSP did not further alter circulating EV miRNA-17 family member expression and nor did it change total miRNA-17 family levels in peri-infarct brain tissue or in EV isolated from this region at 24 h post-tMCAO. Changes in EV packaged miRNA expression was validated in patients with stroke, particularly those with SVD and corroborated pre-clinically. Together, altered circulating EV levels of miRNA-17 family members may reflect the chronic sequelae underlying cerebrovascular SVD rather than the acute ischemic stroke itself.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30617992</pmid><doi>10.1007/s12975-018-0682-3</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-6462-4109</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1868-4483
ispartof Translational stroke research, 2019-10, Vol.10 (5), p.495-508
issn 1868-4483
1868-601X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733813
source MEDLINE; ProQuest Central (Alumni); ProQuest Central UK/Ireland; SpringerNature Journals; ProQuest Central
subjects Animals
Biomedical and Life Sciences
Biomedicine
Brain Ischemia - blood
Brain research
Cardiology
Cerebral Small Vessel Diseases - blood
Disease Models, Animal
Extracellular Vesicles - metabolism
Genes
Ischemia
Male
MicroRNAs
MicroRNAs - blood
Neurology
Neurosciences
Neurosurgery
Original
Original Article
Patients
Rats, Inbred SHR
Rats, Inbred WKY
Software
Statistical analysis
Stroke
Stroke - blood
Stroke - complications
Thermal cycling
Validation studies
Vascular Surgery
Veins & arteries
title Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A06%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20Extracellular%20Vesicle%20MicroRNA%20Expression%20in%20Ischemic%20Stroke%20and%20Small%20Vessel%20Disease&rft.jtitle=Translational%20stroke%20research&rft.au=van%20Kralingen,%20Josie%20C.&rft.date=2019-10-01&rft.volume=10&rft.issue=5&rft.spage=495&rft.epage=508&rft.pages=495-508&rft.issn=1868-4483&rft.eissn=1868-601X&rft_id=info:doi/10.1007/s12975-018-0682-3&rft_dat=%3Cproquest_pubme%3E2920241253%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920241253&rft_id=info:pmid/30617992&rfr_iscdi=true